INTRODUCTION

MATERIALS AND METHODS
This study included all pregnant women who completed either Research is required to understand if this relates to characteristics of the carer making the offer of screening, language and/or cultural barriers to care or specific collective cultural or religious views held by women from these ethnicities. The lower completed first trimester versus second trimester prenatal screening in deprived areas, as well as variation by DHB, may relate to the availability of ultrasound and/or laboratory services in specific regions. Cost may be a contributing factor to inequity in timing of completed prenatal screening uptake, as first trimester screening incurs a part-charge to the individual, while second trimester screening is fully funded. Systemic factors within the NZ maternity model of care may also be contributory with a potential disconnect occurring for the woman between primary medical care and later registration with a Lead Maternity Carer in the first trimester.
K E Y W O R D S
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The laboratory receives information on each woman screened, including: (i) maternal characteristics, age, ethnicity, domicile of residence, weight, certain co-morbidities, nature of conception; (ii) ultrasound dating; and (iii) NT measurement (for combined first trimester screening only).
For combined first trimester screening, ultrasound dating is based on the earliest possible crown-rump length, but not beyond 13 weeks six days or 84 mm. The NT may be reported from a fetus with a crown-rump length in the range 45-84 mm.
NT ultrasound is only partly publicly funded. First trimester serum (MSS1) is reported within the gestation period of 9 weeks until 13 weeks six days. A completed combined first trimester screen is defined as serum and ultrasound within the above parameters.
Serum received beyond this and until 19 weeks six days is analysed as maternal serum in the second trimester (second trimester screening, MSS2). Serum analytes for first trimester screening or second trimester screening are publicly funded.
The risk estimate assessment is performed using a program called Lifecycle ® (Perkin Elmer) and is issued for either completed combined first trimester or second trimester screening. Two laboratories in NZ perform the analyses. Both these laboratories have the same service specifications with the National Screening Unit (NSU). One laboratory collates all the data and reports quarterly to the NSU, and it is from these reports that data for this study are taken (from July 2010 to June 2013). This study includes only completed screens.
As this study conforms to the standards for quality review, ethics approval was not required.
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NZ has a unique model of primary maternity care whereby pregnant women choose a Lead Maternity Carer (LMC) to provide 'a woman and her baby with continuity of care throughout pregnancy, labour and birth and the postnatal period'. 10 being the least deprived and Decile 10 being the most deprived.
14 As the highest proportion of screening occurs in NZ European women aged 30-34, this group was used as the referent for ethnicity and age. 7 Women residing in Decile 1 and 2 neighbourhoods, and women residing in Auckland DHB, were used as referent groups for deprivation scale and geographic location, respectively.
Data are presented as counts and percentages. Univariate logistic regression analyses were used to explore the association between the outcome of completed first trimester screens and each of ethnicity, deprivation, DHB of domicile and age. Explanatory variables found to be significant with univariate analyses were then included in a multivariate logistic regression model and odds ratios (OR) and 95% confidence intervals (CI) calculated. All statistical analyses were performed using SAS V.9.3 (SAS Institute
Inc., Cary, NC, USA). All reported probabilities (P-values) were twosided, with P < 0.05 considered as statistically significant.
RESULTS
There were 119 120 completed prenatal screens available for analysis. Of these, 104 849 were first trimester (88%) and 14 271
were second trimester (12%). Table 1 and Table 2 show the maternal characteristics. More than half of all completed first trimester screens were in NZ European women (57 469, 54%). The lowest uptake of completed first trimester screens was in Maori (10 802, 10%) and Pacific women (4910, 4.7%).
Ethnicity, maternal age, deprivation and DHB of domicile were all significant independent predictors of completed first versus second trimester screening (Table 3 ). In the multivariable model, Women younger than 30 years were less likely to have completed first trimester screening than women age 30-34 years.
Women aged 40 years and older were also significantly less likely to be screened in the first trimester.
A clear gradient existed with socioeconomic status whereby the higher the level of deprivation, the less likely a woman was 
DISCUSSION
In this study of NZ women who completed prenatal screening,
Maori and Pacific women were found to have the lowest uptake of screening in the first trimester, after adjusting for maternal age, deprivation index and DHB of domicile. Combined first trimester screening has a better sensitivity than second trimester screening. By analysing timing of screening, rather than whether or not screening occurred at all, the current research adds to the growing literature on ethnic inequalities in prenatal care
provision.
Given the limited gestational age window for first trimester screening, it may be that uptake of MSS2 is a proxy for delayed confirmation of pregnancy and/or registration with an LMC. In 2013, 39.1% of women registered with an LMC after the first trimester, but Maori and Pacific women had higher rates of late registration. 15 Furthermore, the rate of late registration was notably higher in some DHBs, for example Counties Manukau (47.5%),
where almost one-third of the pregnant population is of Pacific Island descent. 15, 16 In our study, Pacific women had the lowest uptake of first trimester screening and were over-represented in second trimester screening.
Caution is required in presuming earlier registration with an LMC may improve completed first trimester uptake for women who wish to be screened. In a 2014 NZ study, 80% of pregnant of the ultrasound -this may be prohibitive, especially for those most deprived. Another could be that first trimester screening is a two-step process to be completed within a short time frame.
Comparatively, second trimester screening, a one-step, fully funded process is potentially easier for women to navigate. The first trimester screening process represents inequity within our system with only those who can afford the scan being able to access the better performing test. In Denmark, the introduction of fully funded combined first trimester screening resulted in >90% of women completing first trimester screening.
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The findings of our research will have significant implications for a non-invasive prenatal testing (NIPT) program in NZ.
Currently this is a user-pays system. Any proposed introduction of publicly funded NIPT will require an understanding of the current barriers that exist within the status quo of prenatal screening.
It may be that NIPT is more cost-effective (given the number of redundant incomplete first trimester screens) and promotes better equity of access -with a one-step process that is not strictly gestation-dependent.
Prenatal screening is embedded in maternity care in NZ. A screening program that promotes equitable access must ensure that all women are offered prenatal screening and can access it within the time frame required. We do not currently know whether all eligible women are offered prenatal screening and, of those women who are offered and accept it, what percentage go on to complete it and why or why not.
Qualitative research to understand the reasons for higher rates of second trimester screening (versus combined first trimester screening) as well as possibly incomplete screens in Maori and Pacific women could be achieved through focus groups. Such research would provide valuable insights into the current barriers that exist for women, which is imperative in ensuring the delivery of an equitable screening program within the NZ maternity system.
